Cheng Michael, Nassim Janelle, Angha Ario, Srey Krisna, Canales Alexander, Kiffin Chauniqua, Ashmawy Yessin, Rosenthal Andrew A
Florida Atlantic University Charles E. Schmidt College of Medicine, 777 Glades Road, Boca Raton, FL 33431, USA.
Saba University School of Medicine, 27 Jackson Road, Devens, MA 01434, USA.
Case Rep Obstet Gynecol. 2016;2016:7963874. doi: 10.1155/2016/7963874. Epub 2016 Aug 18.
Factor XIII deficiency is a rare inherited coagulopathy. Factor XIII is the last clotting factor in the coagulation cascade to insure strength and stability to fibrin clots. Without this enzyme, the fibrous clot is unstable and nonresistant to fibrinolysis. Gravid women with this congenital disease are especially at risk for complications including miscarriages and hemorrhage without appropriate interventions. We present a case of a woman in her 20s with Factor XIII deficiency who was treated with cryoprecipitate and had a successful normal spontaneous vaginal delivery; subsequently, patient suffered from postpartum hemorrhage and consumptive coagulopathy due to consumption of Factor XIII, requiring emergency surgical intervention. Intraoperative management was challenged by an ethical dilemma involving the patient's religious beliefs about not receiving blood. This paper will discuss the mechanism of Factor XIII and the medical and surgical management involved with this patient.
因子 XIII 缺乏症是一种罕见的遗传性凝血病。因子 XIII 是凝血级联反应中的最后一个凝血因子,可确保纤维蛋白凝块的强度和稳定性。没有这种酶,纤维凝块就不稳定且不耐纤维蛋白溶解。患有这种先天性疾病的孕妇如果没有适当的干预措施,尤其有发生包括流产和出血在内的并发症的风险。我们报告一例 20 多岁患有因子 XIII 缺乏症的女性病例,该患者接受了冷沉淀治疗并成功顺产;随后,患者因因子 XIII 消耗而发生产后出血和消耗性凝血病,需要紧急手术干预。术中管理面临一个伦理困境,即患者关于不接受输血的宗教信仰。本文将讨论因子 XIII 的机制以及该患者的内科和外科治疗。